Real-time real-world analysis of seasonal influenza vaccine effectiveness: Method development and assessment of a population-based cohort in Stockholm county, Sweden, seasons 2011/12 to 2014/15

Eurosurveillance

Volumn 21, Issue 43, 2016, Pages

  Leval, A ^a,b,c   Hergens, Mp ^b   Persson, K ^a   Örtqvist, Åke ^a,b  

^a Department of Communicable Disease Control and Prevention for Stockholm County ^*  (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Janssen Cilag AB   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC PATIENT; COHORT ANALYSIS; DRUG EFFICACY; FEMALE; HUMAN; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PNEUMONIA; PUBLIC HEALTH; RETROSPECTIVE STUDY; SEASONAL INFLUENZA; VACCINE FAILURE; YOUNG ADULT; HEALTH SURVEY; HOSPITALIZATION; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; SEASON; SPECIES DIFFERENCE; STATISTICS AND NUMERICAL DATA; SWEDEN; VACCINATION; VERY ELDERLY; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SEASONS; SPECIES SPECIFICITY; SWEDEN; VACCINATION; YOUNG ADULT;

EID: 85013765472     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES.2016.21.43.30381     Document Type: Article

References (33)

1. Valenciano M, Ciancio B, I-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012;17(39):20281.PMID: 23041022
2. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010;28(46):7381-8. DOI: 10.1016/j.vaccine.2010.09.010 PMID: 20851086
3. Belongia EA, Shay DK. Influenza vaccine for community-acquired pneumonia. Lancet. 2008;372(9636):352-4. DOI:10.1016/S0140-6736(08)61137-X PMID: 18675671
4. Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clin Infect Dis. 2012;55(7):951-9. DOI:10.1093/cid/cis574 PMID: 22843783
5. Pebody RG, Mølbak K. Importance of timely monitoring of seasonal influenza vaccine effectiveness. Euro Surveill. 2016;21(16):30209. DOI: 10.2807/1560-7917.ES.2016.21.16.30209 PMID: 27123870
6. Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2010; (2):CD004876.PMID: 20166072
7. Beyer WEP, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus ADME. Cochrane re-arranged: support for policies to vaccinate elderly people against influenza. Vaccine. 2013;31(50):6030-3. DOI: 10.1016/j.vaccine.2013.09.063 PMID: 24095882
8. Carlsson AC, Wändell P, Ösby U, Zarrinkoub R, Wettermark B, Ljunggren G. High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health.BMC Public Health. 2013;13(1):670. DOI: 10.1186/1471-2458-13-670 PMID: 23866784
9. JSzegö J. Bebyggelsens mosaik [The mosaic of the settlement]. Rapport 7:2009. Stockholm: Regionplanekontoret; 2009. Swedish. Available from: http://www.rufs.se/publikationer/20092/20097-bebyggelsens-mosaik/http://
10. World Health Organization (WHO). International statistical classification of diseases and related health problems. 10th Revision. Volume 2. Instruction manual. 2010 ed. Geneva: WHO; 2011. Available from: http://www.who.int/classifications/icd/ICD10Volume2_en_2010.pdf
11. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11(1):450. DOI: 10.1186/1471-2458-11-450 PMID: 21658213
12. Public Health Agency of Sweden Influenza in Sweden 2014-2015 Season. [Accessed 5 Aug 2016] Available from: https://www.folkhalsomyndigheten.se/pagefiles/21868/Influenza-in-Sweden-2014-2015.pdf
13. Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337-44. DOI: 10.1093/ije/dyi274 PMID: 16368725
14. Örtqvist A, Granath F, Askling J, Hedlund J. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J. 2007;30(3):414-22. DOI: 10.1183/09031936.00135306 PMID: 17537767
15. Jefferson TO, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2007; (2):CD001269.PMID: 17443504
16. Michiels B, Govaerts F, Remmen R, Vermeire E, Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine. 2011;29(49):9159-70. DOI: 10.1016/j.vaccine.2011.08.008 PMID: 21840359
17. Jackson ML, Yu O, Nelson JC, Naleway A, Belongia EA, Baxter R, et al. Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol. 2013;178(8):1327-36. DOI: 10.1093/aje/kwt124 PMID: 23978527
18. Remschmidt C, Wichmann O, Harder T. Frequency and impact of confounding by indication and healthy vaccine bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect Dis. 2015;15(1):429. DOI: 10.1186/s12879-015-1154-y PMID: 26474974
19. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebocontrolled trial. JAMA. 1994;272(21):1661-5. DOI: 10.1001/jama.1994.03520210045030 PMID: 7966893
20. Darvishian M, Gefenaite G, Turner RM, Pechlivanoglou P, Van der Hoek W, Van den Heuvel ER, et al. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J Clin Epidemiol. 2014;67(7):734-44. DOI: 10.1016/j.jclinepi.2014.02.009 PMID: 24768004
21. McLean HQ, Thompson MG, Sundaram ME, Meece JK, McClure DL, Friedrich TC, et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis. 2014;59(10):1375-85. DOI: 10.1093/cid/ciu680 PMID: 25270645
22. Voordouw AC, Sturkenboom MC, Dieleman JP, Stijnen T, Smith DJ, van der Lei J, et al. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. JAMA. 2004;292(17):2089-95. DOI: 10.1001/jama.292.17.2089 PMID: 15523069
23. Kissling E, Valenciano M, I-MOVE Case-Control Studies Team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill. 2012;17(15):20146.PMID: 22516046
24. Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen JM, Nunes B, et al. Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre casecontrol study. Euro Surveill. 2013;18(5):20390.PMID: 23399425
25. Valenciano M, Kissling E, Reuss A, Jiménez-Jorge S, Horváth JK, Donnell JM, et al. The European I-MOVE Multicentre 2013-2014 Case-Control Study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2). Vaccine. 2015;33(24):2813-22. DOI: 10.1016/j.vaccine.2015.04.012 PMID: 25936723
26. Flannery B, Clippard J, Zimmerman RK, Nowalk MP, Jackson ML, Jackson LA, et al. Early estimates of seasonal influenza vaccine effectiveness - United States, January 2015. MMWR Morb Mortal Wkly Rep. 2015;64(1):10-5.PMID: 25590680
27. Pebody R, Warburton F, Andrews N, Ellis J, von Wissmann B, Robertson C, et al. Effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 end of season results. Euro Surveill. 2015;20(36):30013. DOI: 10.2807/1560-7917.ES.2015.20.36.30013 PMID: 26535911
28. Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, et al. A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season. Clin Infect Dis. 2016;63(1):21-32. DOI: 10.1093/cid/ciw176 PMID: 27025838
29. World Health Organisation (WHO). Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season. [Accessed 10 May 2016]. Available from: http://www.who.int/influenza/vaccines/virus/recommendations/201409_recommendation.pdf
30. European Commission. Council Recommendation of 22 December 2009 on seasonal influenza vaccination (2009/1019/ EU) Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 29.12.2009:L 348/71. Available from: http://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32009H1019
31. Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill. 2014;19(6):20701. DOI: 10.2807/1560-7917.ES2014.19.6.20701 PMID: 24556348
32. Rondy M, Launay O, Puig-Barberà J, Gefenaite G, Castilla J, de Gaetano Donati K, et al. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. Euro Surveill. 2015;20(2):21011. DOI: 10.2807/1560-7917.ES2015.20.2.21011 PMID: 25613779
33. Smittskydd Stockholm. Influensasäsongen 2015-2016 [Influenza season 2015-2016]. 27 June 2015. Available from: http://www.vardgivarguiden.se/behandlingsstod/smittskydd/dokument/statistik/influensa/influensasasongen-2015-2016/